Condition

Pemphigus clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Pemphigus clinical trials that are recruiting, at sites in 3 countries (most in France (2), Guadeloupe (1), China (1)). By phase: Phase 4 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Pemphigus clinical trials

StudyPhaseWhereStatusRegistered
Evaluating B007 for treating pemphigus Phase 2/3 Beijing and 11 other locations Recruiting Jun 12, 2024
Assessing the burden of rare skin diseases — Bobigny and 14 other locations Recruiting Jul 20, 2023
Personalized maintenance therapy versus standard treatment for pemphigus Phase 4 Amiens and 33 other locations Recruiting Jun 12, 2023

All recruiting trials (3)

Related topics

AlbinismDermatologic DiseaseEctodermal DysplasiaNeurofibromatosis Type 1Rituximab

Quick answers

How many Pemphigus clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in France (2 trials), Guadeloupe (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.